Format

Send to

Choose Destination
Onco Targets Ther. 2017 Aug 11;10:4023-4028. doi: 10.2147/OTT.S136821. eCollection 2017.

Low concentration of quercetin antagonizes the invasion and angiogenesis of human glioblastoma U251 cells.

Author information

1
Department of Neurosurgery.
2
Institute of Esophageal Tumor, Renmin Hospital, Hubei University of Medicine, Shiyan, Hubei, People's Republic of China.

Abstract

Glioblastoma is the most aggressive type of brain tumor with a very poor prognosis. Therefore, it is always of great importance to explore and develop new potential treatment for glioblastoma. Quercetin, a flavonoid present in a variety of human foods, has been shown to inhibit various tumor cell proliferation. In this study, we found that treating human glioblastoma U251 cells with 10 μg/mL quercetin for 24 hours, a concentration that was far below the IC50 (113.65 μg/mL) and at which quercetin failed to inhibit cell proliferation, inhibited cell migration (30%) and cell invasion as examined by wound scratch assay and transwell assay, respectively. We further showed that 10 μg/mL quercetin inhibited cell migration and tube formation of human umbilical vein endothelial cells induced by the conditioned medium derived from U251 cell culture. The inhibitory effect of quercetin on migration and angiogenesis is possibly mediated through the downregulation of protein levels of VEGFA, MMP9, and MMP2 as detected by Western blot. Our findings demonstrated that low concentration of quercetin antagonized glioblastoma cell invasion and angiogenesis in vitro.

KEYWORDS:

angiogenesis; glioblastoma; invasion; metastasis; quercetin

Conflict of interest statement

Disclosure The authors report no conflicts of interest in this work.

Supplemental Content

Full text links

Icon for Dove Medical Press Icon for PubMed Central
Loading ...
Support Center